Consegna Pharma, Inc.
Consegna Pharma Inc. is a specialty pharmaceutical company dedicated to creating best-in-class long-acting medications. Their mission focuses on developing innovative solutions such as long-acting Naloxone to combat opioid overdoses, aiming to improve overdose reversal treatments and prevent secondary overdoses. The company is located at 2403 Sidney St., Suite 255, Pittsburgh, PA 15203.
Industries
biotechnology
pharmaceutical
Nr. of Employees
small (1-50)
Products
Long-acting naloxone formulation (12–24 hour release)
A sustained-release naloxone formulation designed to provide 12–24 hours of drug exposure to reduce the need for repeated dosing and help prevent renarcotization after opioid overdose.
Long-acting naloxone formulation (12–24 hour release)
A sustained-release naloxone formulation designed to provide 12–24 hours of drug exposure to reduce the need for repeated dosing and help prevent renarcotization after opioid overdose.
Expertise Areas
- Long-acting drug delivery
- Formulation development
- Opioid overdose therapeutics
- Sustained-release product design
Key Technologies
- Sustained-release / extended-release formulations
- Long-acting drug delivery systems
- Controlled-release formulation techniques